Dopamine Receptor D1 Is Exempt from Transforming Growth Factor<i>β</i>-Mediated Antifibrotic G Protein-Coupled Receptor Landscape Tampering in Lung Fibroblasts-Reference-Cited by-同舟云学术

Dopamine Receptor D1 Is Exempt from Transforming Growth Factorβ-Mediated Antifibrotic G Protein-Coupled Receptor Landscape Tampering in Lung Fibroblasts

Published:2023-04-06 Issue:3 Volume:386 Page:277-287
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Gao Ashley Y.,Diaz Espinosa Ana M.,Nguyen Ba Bao N.,Link Patrick A.,Meridew Jeffrey,Jones Dakota L.,Gibbard Daniel F.,Tschumperlin Daniel J.,Haak Andrew J.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference60 articles.

1. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors

2. TBK1 regulates YAP/TAZ and fibrogenic fibroblast activation;Aravamudhan;Am J Physiol Lung Cell Mol Physiol,2020

3. The IUPHAR/BPS guide to pharmacology in 2020: extending immunopharmacology content and introducing the IUPHAR/MMV guide to malaria pharmacology;Armstrong;Nucleic Acids Res,2020

4. MicroRNA-144-3p targets relaxin/insulin-like family peptide receptor 1 (RXFP1) expression in lung fibroblasts from patients with idiopathic pulmonary fibrosis

5. Cellular Mechanisms of Tissue Fibrosis. 7. New insights into the cellular mechanisms of pulmonary fibrosis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Could a Nebulized or Dry Powder Inhalation of a Dopamine D1R Agonist Be a Treatment of Idiopathic Pulmonary Fibrosis?;Journal of Pharmacology and Experimental Therapeutics;2023-08-17

2. A fibroblast-dependent TGFβ1/sFRP2 noncanonical Wnt signaling axis underlies epithelial metaplasia in idiopathic pulmonary fibrosis;2023-08-05